We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sanofi | BIT:SANF | Italy | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
0.00 | - |
Date | Time | Source | Headline |
---|---|---|---|
09/1/2025 | 06:00 | UKREG | Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a.. |
09/1/2025 | 06:00 | UKREG | Press Release: New Sarclisa subcutaneous formulation met co-primary.. |
23/12/2024 | 06:00 | UKREG | Press Release: Sanofi initiates phase 3 program for PCV21 and expands.. |
23/12/2024 | 06:00 | UKREG | Communiqué de presse : Sanofi lance un programme de phase III pour son.. |
19/12/2024 | 17:00 | UKREG | Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration.. |
19/12/2024 | 17:00 | UKREG | Presse release: Jean-Paul Kress to join Sanofi's Board of Directors |
17/12/2024 | 12:30 | UKREG | Press Release: Duvakitug positive phase 2b results demonstrate.. |
17/12/2024 | 12:30 | UKREG | Communiqué de presse : Les résultats positifs de phase IIb concernant le.. |
17/12/2024 | 06:30 | UKREG | Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » |
17/12/2024 | 06:30 | UKREG | Press Release: Availability of the Q4 2024 Aide-mémoire |
1 Year Sanofi Chart |
Intraday Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions